Mobile group Vodafone said on Wednesday finance chief Luka Mucic will be stepping down from his role by early next year, adding that a search for his successor is ongoing.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated for the treatment of primary biliary cholangitis (PBC) and also provides sustained biochemical response in adults with PBC regardless of prior treatment history. Another analysis provides evidence supporting that Livdelzi delivered clinically and.

The company has seen sales hit by alternative compounded versions of its blockbuster weight-loss and diabetes drugs, particularly in the U.S.

Cognizant's strong financial performance, driven by acquisitions and organic growth in Health Sciences and Financial Services, supports a positive outlook and a Buy recommendation. Strategic partnerships, like with NVIDIA, and investments in AI and healthcare IT spending are expected to drive future growth and higher free cash flow. Risks include decreased outsourced spending in the banking sector and heavy dependence on North America, but Cognizant's diversification efforts are promising.

Data highlighted in late-breaker poster presentation shows that imdusiran achieves functional cure in chronic hepatitis B (cHBV) patients when combined with VTP-300 and low dose nivolumab In a Phase 1a/1b clinical trial, AB-101, an oral PD-L1 inhibitor, has shown to be generally safe and well-tolerated with evidence of high receptor occupancy and no liver dysfunction in cHBV patients WARMINSTER, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the presentation of five posters, including one late-breaker, highlighting imdusiran, its RNAi therapeutic and AB-101, …

Press ReleaseCybernet and Nokia redefine Pakistan's network landscape with 1.2T-per-lambda backbone Cybernet has selected Nokia's innovative 1830 Global Express (GX) platform with integrated optical line system capabilities and ICE7 coherent optics. Cybernet's new network will provide connectivity services to over 25 cities across Pakistan.

HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Vaalco Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today provided additional details regarding its Capital Markets Day presentation on Wednesday, May 14, 2025. The presentation will begin at 8 a.m. Central Time (2 p.m. London Time) and is expected to conclude by around 10:00 a.m. Central Time (4 p.m. London Time).

DA-1241 Significantly Decreased Plasma ALT levels, with a Mean Reduction of 22.8 U/L After 16 Week-Treatment Controlled Attenuation Parameter (CAP) Score Improved by 23.0 dB/m, Indicating Reduced Liver Fat Content Improvement in Systemic Inflammatory and Fibrosis Biomarkers Supports Beneficial Effects on Liver Health CAMBRIDGE, Mass. , May 7, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that data from its Phase 2a clinical trial of DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, in patients with presumed metabolic dysfunction-associated steatohepatitis (MASH), demonstrates both hepatoprotective and glucose-regulating effects.

Cytokinetics, Incorporated (NASDAQ:CYTK ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Diane Weiser - Senior Vice President, Corporate Affairs Robert Blum - President & Chief Executive Officer Andrew Callos - Executive Vice President & Chief Commercial Officer Fady Malik - Executive Vice President, R&D Isaac Ciechanover - EVP Corporate Development and Chief Business Officer Stuart Kupfer - Senior Vice President & Chief Medical Officer Sung Lee - Executive Vice President & Chief Financial Officer Conference Call Participants Sean McCutcheon - Raymond James Salim Syed - Mizuho Gena Wang - Barclays Paul Choi - Goldman …

SEOUL, South Korea, May 07, 2025 (GLOBE NEWSWIRE) -- Global enter-tech platform BIGC has opened ticket sales for YE(Kanye West)'s concert in Korea, YE LIVE IN KOREA, PRESENTED BY COUPANG PLAY. ‘YE LIVE IN KOREA' will take place on Saturday, May 31 at 8:00 PM KST at Incheon Munhak Stadium and marks YE's first solo concert in Korea.

BS Teh, Seagate's chief commercial officer, told CNBC that the company is aiming to launch a 100-terabyte hard drive by 2030. The largest hard disk drive Seagate currently produces is the 36-terabyte Exos M model, which it launched in January.

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations. The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.

Obesity drugmaker Novo Nordisk on Wednesday posted first-quarter operating profit above analyst forecasts and cut its operating profit and sales outlook for the year.

Key Tronic Corporation (NASDAQ:KTCC ) Q3 2025 Results Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Anthony Voorhees - Executive Vice President of Administration, Chief Financial Officer, and Treasurer Brett Larsen - President and Chief Executive Officer Conference Call Participants Bill Dezellem - Titan Capital George Melas - MKH Management Sheldon Grodsky - Grodsky Associates, Inc. Operator Good day and welcome to the Key Tronic Q3 Fiscal Year 2025 Investor Call. Today's conference is being recorded.

HAMILTON, Bermuda , May 7, 2025 /PRNewswire/ -- Flex LNG Ltd ("Flex LNG" or the "Company") will release its unaudited financial results for the first quarter of 2025 on Wednesday May 21, 2025, on or about 07:00 CEST (1:00 a.m. EST). In connection with the earnings release, a live video webcast will be held at 15:00 CEST (9:00 a.m.

7 May 2025 - Financial report for the period 1 January 2025 to 31 March 2025

Silvercorp Metals Inc. is rated a "Buy" due to its strong financial position, cost-efficient operations, and positive outlook for silver prices. The company reported significant revenue and production increases in FY2025, driven by rising metal prices and efficient mining operations. Silvercorp's strategic focus includes generating free cash flow, organic growth, asset acquisitions, and responsible mining, enhancing shareholder value.

On Holding AG has continued to rapidly capture market share in running shoes, solidifying the company's position in the industry. Competition remains noteworthy regardless. The Q1 report is set to continue On's brand growth story. The future outlook is important in the report, amid tariff uncertainty. The current growth narrative supports ONON's expensive valuation. While I estimate upside to a fair value of $57.5, potential changes in the narrative are still quick to change the value.

WISeKey and OISTE.ORG Generate and Launch a Post-Quantum Cryptography Root Key to Defend Against Quantum Cyber Threats